The Phenoxyphenol Compound diTFPP Mediates Exogenous C2-Ceramide Metabolism, Inducing Cell Apoptosis Accompanied by ROS Formation and Autophagy in Hepatocellular Carcinoma Cells
Open Access
- 5 March 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (3), 394
- https://doi.org/10.3390/antiox10030394
Abstract
Hepatocellular carcinoma (HCC) is a severe disease that accounts for 80% of liver cancers. Chemotherapy is the primary therapeutic strategy for patients who cannot be treated with surgery or who have late-stage HCC. C2-ceramide is an effective reagent that has been found to inhibit the growth of many cancer types. The metabolism of C2-ceramide plays a vital role in the regulation of cell death/cell survival. The phenoxyphenol compound 4-{2,3,5,6-tetrafluoro-4-[2,3,5,6-tetrafluoro-4-(4-hydroxyphenoxy)phenyl]phenoxy}phenol (diTFPP) was found to have a synergistic effect with C2-ceramide, resulting in considerable cell death in the HA22T HCC cell line. diTFPP/C2-ceramide cotreatment induced a two- to threefold increase in cell death compared to that with C2-ceramide alone and induced pyknosis. Annexin V/7-aminoactinomycin D (7AAD) double staining and Western blotting indicated that apoptosis was involved in diTFPP/C2-ceramide cotreatment-mediated cell death. We next analyzed transcriptome alterations in diTFPP/C2-ceramide-cotreated HA22T cells with next-generation sequencing (NGS). The data indicated that diTFPP treatment disrupted sphingolipid metabolism, inhibited cell cycle-associated gene expression, and induced autophagy and reactive oxygen species (ROS)-responsive changes in gene expression. Additionally, we assessed the activation of autophagy with acridine orange (AO) staining and observed alterations in the expression of the autophagic proteins LC3B-II and Beclin-1, which indicated autophagy activation after diTFPP/C2-ceramide cotreatment. Elevated levels of ROS were also reported in diTFPP/C2-ceramide-treated cells, and the expression of the ROS-associated proteins SOD1, SOD2, and catalase was upregulated after diTFPP/C2-ceramide treatment. This study revealed the potential regulatory mechanism of the novel compound diTFPP in sphingolipid metabolism by showing that it disrupts ceramide metabolism and apoptotic sphingolipid accumulation.Funding Information
- Ministry of Science and Technology, Taiwan (MOST106-2314-B-037-053-MY3, MOST107-2320-B-037-023, MOST108-2314-B-037-051, MOST109-2313-B-037-001)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH106-6R36, KMUH107-7R33, KMUH108-8R38)
- NSYSU-KMU (NSYSU-KMU110-P024)
This publication has 66 references indexed in Scilit:
- Ceramide and the mitochondrial respiratory chainBiochimie, 2014
- Role of the Crosstalk between Autophagy and Apoptosis in CancerJournal of Oncology, 2013
- Autophagosomal Membrane Serves as Platform for Intracellular Death-inducing Signaling Complex (iDISC)-mediated Caspase-8 Activation and ApoptosisOnline Journal of Public Health Informatics, 2012
- c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cellsJournal of Translational Medicine, 2011
- Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2ABlood, 2011
- Protein misfolding disorders and macroautophagyCurrent Opinion in Cell Biology, 2011
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Direct interaction between the inhibitor 2 and ceramideviasphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signalingThe FASEB Journal, 2008
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009Cell Death & Differentiation, 2008
- Apoptosis and autophagy: regulatory connections between two supposedly different processesApoptosis, 2007